Open AccessImmune-Mediated Adverse Effects of Checkpoint Inhibitors: A Clinical Experience
Author(s) -
Jan Juřica,
Roman Goněc,
A. Bártová,
Jana Gregorová
Publication year - 2022
Publication title -
european pharmaceutical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.151
H-Index - 7
ISSN - 2453-6725
DOI - 10.2478/afpuc-2022-0006
Subject(s) - medicine , ipilimumab , adverse effect , infliximab , nivolumab , vedolizumab , prednisone , cancer , immunotherapy , ulcerative colitis , tumor necrosis factor alpha , disease